Your session is about to expire
← Back to Search
Amino Acid Supplement
Amino Acid Supplement for Insulin-Like Growth Factor I (IGF-I)
Phase 2
Waitlist Available
Led By David Crowley, MD
Research Sponsored by ZandA Technologies, llc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (day 1) and 91 days
Awards & highlights
Study Summary
This trial studies the safety and effectiveness of an amino acid supplement to increase the hormone IGF-1 in adults aged 35-75. BMI and medications must be maintained for the study.
Eligible Conditions
- Insulin-Like Growth Factor I (IGF-I)
- Healthy Subjects
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (day 1) and 91 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (day 1) and 91 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Somatomedins
The difference in serum IGF-1 concentrations from baseline up to 60 days of supplementation between Amino Acid Supplement (AAS) compared to placebo.
Somatomedins
Secondary outcome measures
Amino Acids
Amino Acids
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Amino Acid SupplementExperimental Treatment1 Intervention
Participants will be instructed to take four (4) capsules of Amino Acid Supplement with a full glass of water daily for up to 90 days, starting on day 1. No substance other than water (i.e., food, drink other than water, and/or medication, supplement, vitamin, and/or mineral) can be consumed two hours before or after taking the Investigational Product (IP). The IP must be consistently consumed immediately before nighttime sleep throughout the study.
If a dose is missed participants are instructed to record the missed dose in their study journal. Missed doses will not be taken at a later time or date. If any substance other than water is consumed two hours before or after taking the IP, that IP use will be counted as a missed dose. Participants will be advised not to exceed four (4) capsules daily.
Group II: PlaceboPlacebo Group1 Intervention
Participants will be instructed to take four (4) capsules of Placebo with a full glass of water daily for up to 90 days, starting on day 1. No substance other than water (i.e., food, drink other than water, and/or medication, supplement, vitamin, and/or mineral) can be consumed two hours before or after taking the placebo. The placebo must be consistently consumed immediately before nighttime sleep throughout the study.
If a dose is missed participants are instructed to record the missed dose in their study journal. Missed doses will not be taken at a later time or date. If any substance other than water is consumed two hours before or after taking the placebo, that placebo use will be counted as a missed dose. Participants will be advised not to exceed four (4) capsules daily.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Amino Acid Supplement
2022
Completed Phase 2
~120
Find a Location
Who is running the clinical trial?
KGK Science Inc.Industry Sponsor
78 Previous Clinical Trials
6,040 Total Patients Enrolled
ZandA Technologies, llcLead Sponsor
David Crowley, MDPrincipal InvestigatorKGK Science Inc.
35 Previous Clinical Trials
2,633 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have cancer, except for a certain type of skin cancer that has been completely removed without needing chemotherapy or radiation. If you have been in remission from cancer for more than five years, you can still participate.I'm sorry, but you didn't provide a specific criterion after "Or." Could you please provide more information or another criterion for me to summarize?You are using two forms of birth control.You have an intrauterine device (IUD) inserted in your uterus.You are allergic or sensitive to any of the ingredients in the experimental medication.You have or have had a serious brain disease that affects memory and thinking, like Alzheimer's disease or vascular dementia.You have had a problem with alcohol or drugs in the past two years or are currently seeking treatment for alcohol or substance abuse.You have a history of stomach, liver, or kidney problems, or any other condition that could affect how medications are processed in your body, according to the doctor's opinion.
Research Study Groups:
This trial has the following groups:- Group 1: Amino Acid Supplement
- Group 2: Placebo
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has the Amino Acid Supplement been validated by the FDA?
"Although there is some evidence for its safety, the efficacy of Amino Acid Supplement has yet to be established. As such, our team assigned it a score of 2 on the 1-3 scale."
Answered by AI
Are elderly individuals eligible to partake in this research experiment?
"As per the inclusion parameters, applicants must be between 35 and 75 years old. There are 50 studies recruiting patients younger than 18 while 372 require participants above 65."
Answered by AI
Who is eligible to volunteer for this research endeavor?
"In order to be accepted into this medical trial, applicants must have a record of insulin-like growth factor i and fall within the ages of 35 and 75. Approximately 120 persons will be included in the study."
Answered by AI
Do recruitment efforts for this research endeavor remain ongoing?
"Records hosted on clinicaltrials.gov demonstrate that this medical trial is still open for enrollment, having been initially published on November 1st 2022 and last revised on October 25th 2022."
Answered by AI
What is the enrollment count for this research project?
"Affirmative. According to clinicaltrials.gov, the study first made its appearance on November 1st 2022 and was most recently revised on October 25th 2022. Currently, this research trial intends to recruit 120 participants from a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger